Chronic Obstructive Pulmonary Disease (COPD)

COPD, characterized by airway inflammation and lung tissue destruction, poses significant morbidity and mortality risks, particularly in smokers and older adults. Management includes smoking cessation and symptom relief.

Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease characterized by airflow limitation and persistent respiratory symptoms. Common symptoms include shortness of breath, chronic cough, and sputum production. COPD primarily results from long-term exposure to irritants such as cigarette smoke, air pollution, and occupational dusts and chemicals. The disease encompasses two main conditions: emphysema, involving damage to the lung tissue, and chronic bronchitis, characterized by inflammation and narrowing of the airways. COPD is a leading cause of morbidity and mortality worldwide, with treatments aimed at relieving symptoms, improving quality of life, and slowing disease progression through smoking cessation, medications, and pulmonary rehabilitation.

    Related Conference of Chronic Obstructive Pulmonary Disease (COPD)

    October 23-24, 2025

    13th Annual Congress on Pulmonary and Critical Care

    Paris, France
    April 27-28, 2026

    2nd World Congress on Pathology and Laboratory Medicine

    Paris, Aland Islands
    June 11-12, 2026

    5th World Summit on COPD

    Rome, Italy

    Chronic Obstructive Pulmonary Disease (COPD) Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in